Laura Murphy
About Laura Murphy
Laura Murphy serves as the Director of Training, Organizational Readiness at ArisGlobal, where she has worked since 2022. She holds a Master's degree in Regulatory Science and has extensive experience in drug safety, project management, and implementing safety systems in the pharmaceutical industry.
Current Role at ArisGlobal
Laura Murphy currently serves as the Director of Training, Organizational Readiness at ArisGlobal. She has held this position since 2022, contributing to the development and implementation of training programs aimed at enhancing organizational effectiveness. Her role involves overseeing training initiatives that align with the company's strategic goals.
Previous Experience at ArisGlobal
Laura Murphy has held multiple positions at ArisGlobal prior to her current role. She worked as an Associate Director from 2021 to 2022, and as a Subject Matter Expert - Safety from 2018 to 2020. Additionally, she served as a Senior Subject Matter Expert - Safety from 2020 to 2021. In these roles, she focused on safety systems, validation, and drug safety management.
Educational Background
Laura Murphy earned a Master's degree in Regulatory Science from the University of Maryland Baltimore, where she studied from 2016 to 2018. She also holds a Bachelor's degree in Clinical Laboratory Science from the University of North Carolina at Chapel Hill, completed between 1999 and 2003. Furthermore, she obtained a Master's degree in Public Health from the University of North Carolina at Greensboro, studying from 2003 to 2005.
Pharmaceutical Industry Experience
Laura Murphy has extensive experience in the pharmaceutical industry, particularly in drug safety and pharmacovigilance. She worked as a Pharmacovigilance Manager at Fleet Laboratories from 2008 to 2020, where she managed safety systems and validation processes. Her experience includes signal detection, managing CAPAs, and label copy review.
Contributions to Medical Education
Laura Murphy has contributed to medical education and clinical claims support throughout her career. She has been involved in new product development and project management within the pharmaceutical sector, focusing on developing Key Opinion Leaders (KOLs) and Health Care Professional (HCP) interactions.